670 results on '"Lassen, Jens Flensted"'
Search Results
202. Low molecular weight heparin against venous thromboembolism in patients with cancer
203. Telemedicine in prehospital remote diagnosis and re-routing of a patient with acute ST-elevation myocardial infarction to primary percutaneous coronary intervention
204. Telemedicine for prehospital remote diagnosis in patients with suspected acute myocardial infarction:Experiences from the county of Aarhus
205. Telemedicine used for remote prehospital diagnosing in patients suspected of acute myocardial infarction
206. The quality of routine oral anticoagulant therapy in a large geographical area:A survey of 310,300 inhabitants
207. Praktiske aspekter ved peroral antikoagulansbehandling
208. Antikoagulationsbehandling
209. Antikoagulationsbehandling
210. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: The randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial
211. Consensus from the 7th European Bifurcation Club meeting
212. Pain and discomfort in closure of femoral access coronary angiography. The CLOSuredEvices Used in everyday Practice (CLOSE-UP) pain sub study
213. Coronary Edema Demonstrated by Cardiovascular Magnetic Resonance in Patients With Peri-Stent Inflammation and Aneurysm Formation After Treatment by Drug-Eluting Stents
214. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
215. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: From Western Denmark heart registry
216. Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
217. TCT-355 Coronary Stents In Patients With Diabetes Mellitus: The Diabetes And Drug-Eluting Stent (DiabeDES IV) Randomized Angiography Trial
218. TCT-347 Clinical Outcome Of Biolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus: A SORT OUT V Substudy
219. TCT-297 Stent edge dissections detected by Optical Coherence Tomography, incidence, predictors and 12-month outcome
220. TCT-283 Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound Trial
221. Insect stings:Complications and injury mechanisms
222. 2-Year Patient-Related Versus Stent-Related Outcomes
223. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease
224. Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
225. Use of three-dimensional optical coherence tomography to verify correct wire position in a jailed side branch after main vessel stent implantation
226. Long-term safety and efficacy of drug-eluting stents
227. Simple or Complex Stenting for Bifurcation Coronary Lesions
228. One or two stents for coronary bifurcation lesions?
229. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction
230. Reply
231. Increased Rate of Stent Thrombosis and Target Lesion Revascularization After Filter Protection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
232. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
233. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction
234. Clinical Outcome After Primary Percutaneous Coronary Intervention With Drug-Eluting and Bare Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction
235. Intravascular Ultrasound Assessment of Expansion of the Sirolimus-Eluting (Cypher Select) and Paclitaxel-Eluting (Taxus Express-2) Stent in Patients With Diabetes Mellitus
236. Treatment delays in ST elevation myocardial infarction
237. Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention
238. Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions
239. Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical...
240. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.
241. Routine Thrombectomy in Percutaneous Coronary Intervention for Acute ST-Segment–Elevation Myocardial Infarction
242. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study)
243. Prehospital evaluation in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention
244. When analyses are invalidated by erroneous assumptions
245. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention
246. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
247. Cholesterol reduction following health screening in general practice
248. Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy
249. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction
250. Evaluation of a Simple Dosage Scheme for Transition from Phenprocoumon to Warfarin in Oral Anticoagulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.